Skip to content
AnalystLens

TransDigm Group 8-K Report, Financial Results (Nov 12, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed November 12, 2025
Period End
November 12, 2025
Security
TDG
In the record · 2016–202610-K1210-Q338-K234

TDG filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 234 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Mar ’19Mar ’19
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Material agreement8-K · Jul ’22Jul ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed November 12, 2025. Cited figures are marked; the original filing is the authoritative source.

TransDigm Group (TDG) reported fiscal Q4 2025 (quarter ended September 30, 2025) and full-year fiscal 2025 results that beat the high end of its most recently issued guidance.

Q4 net sales rose 11.5% to $2,437 milliona, net income rose 30.1% to $609 million, and EBITDA As Defined grew 14.9% to $1,320 million with a margin of 54.2%, up about 160 basis points. Fiscal 2025 net sales reached $8,831 million (up 11.2%), EBITDA As Defined was $4,760 million (53.9% margin), and adjusted EPS was $37.33 (up 10%). Management attributed growth to strong commercial aftermarket and defense markets, both growing in double digits in Q4, and to a commercial OEM business that grew in the high single digits.

The quarter was dominated by capital allocation. TransDigm issued $5.0 billionb of new debt in August 2025 and paid a $90.00 per share special dividend, with total dividend and dividend equivalent payments of about $5.2 billion made in September. GAAP EPS was reduced by $2.75 in Q4 due to dividend equivalent payments.

The company also acquired Simmonds Precision Products from RTX Corporation after the quarter end, repurchased shares totaling about $0.5 billionc in fiscal 2025, and repriced and extended term loans, which lowered its spread on Tranche K loans from SOFR+2.75% to SOFR+2.25%. Stockholders' deficit widened to $(9,686) million and long-term debt rose to $29,167 million, reflecting the leveraged recapitalization strategy. For fiscal 2026, TransDigm guided net sales of $9,750 million to $9,950 million (about 11.5% growth at the midpoint) and EBITDA As Defined of $5,075 million to $5,225 million (about 8.2% growth at the midpoint, implying a 52.3% margin).

Guided net income is expected to decline about 5.2% at the midpoint, mainly because of higher interest expense from the Q4 financing. Adjusted EPS guidance of $36.49 to $38.53d implies only about 0.5% growth at the midpoint, a key point for investors to weigh against the strong top-line outlook.

Key Highlights

  1. Q4 FY2025 net sales of $2,437 million rose 11.5% year over year, with organic growth of 10.8%.
  2. Q4 EBITDA As Defined margin expanded to 54.2%, up about 160 basis points, while Q4 adjusted EPS rose 10% to $10.82.
  3. Fiscal 2025 results surpassed the high end of prior revenue and EBITDA As Defined guidance; full-year adjusted EPS was $37.33, up 10%.
  4. TransDigm paid approximately $5.2 billion in special dividend and dividend equivalents in September 2025, funded by $5.0 billion of new debt and cash on hand.
  5. FY2026 guidance calls for net sales of $9,750M–$9,950M and EBITDA As Defined of $5,075M–$5,225M, but adjusted EPS of only $36.49–$38.53 (about 0.5% growth at midpoint) due to higher interest expense.
  6. Acquired Simmonds Precision Products from RTX Corporation after quarter end and repurchased about $0.1 billion of shares in October 2025 at about $1,250 per share.
  7. Stockholders' deficit widened to $(9,686) million and long-term debt reached $29,167 million, increasing leverage and interest burden.

Frequently Asked Questions

  1. Why did TransDigm's fiscal 2026 net income guidance decline while sales and EBITDA are expected to grow?

    Net income guidance of $1,906M–$2,026M compared with $2,074M in fiscal 2025 reflects a roughly 5.2% decline at the midpoint. The company attributes this mainly to additional interest expense from the debt financing completed in the fourth quarter of fiscal 2025, which lowers net income even though operating metrics such as sales and EBITDA As Defined are forecast to rise.

  2. How did the special dividend affect GAAP earnings per share?

    The $90.00 per share special dividend, paid September 12, 2025, triggered dividend equivalent payments to holders of eligible vested options. These payments reduced GAAP EPS by $2.75 in Q4 and by $3.58 for the full fiscal year. The company excludes these payments from adjusted EPS, so the adjusted figures do not reflect this reduction.

  3. What is driving the growth outlook across TransDigm's end markets?

    Management expects commercial OEM revenue to grow in the high single-digit to mid-teens range, reflecting higher aircraft build rates. Commercial aftermarket revenue is expected to grow in the high single-digit range, and defense revenue in the mid to high single-digit range. Q4 aftermarket and defense each grew in double digits, supporting the outlook.

  4. What does the increase in leverage and the stockholders' deficit mean for investors?

    Long-term debt increased to $29,167 million from $24,296 million, and the stockholders' deficit grew to $(9,686) million from $(6,290) million. These changes reflect the leveraged capital return strategy. Cash fell to $2,808 million from $6,261 million. Interest expense is rising, and the company's capital allocation priorities will be a key factor in future earnings and cash flow.

  5. What acquisitions and share repurchases did TransDigm complete?

    After the quarter, TransDigm completed the acquisition of Simmonds Precision Products from RTX Corporation, a designer of fuel and proximity sensing and structural health monitoring solutions. In fiscal 2025 and into October, the company acquired two proprietary aerospace businesses for about $0.9 billion. It repurchased about $0.5 billion of stock in fiscal 2025 at an average price of about $1,247 per share, and an additional $0.1 billion in October 2025 at about $1,250 per share.